Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Molecular Endocrinology (Baltimore, Md.)|April 29, 2006
Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cellsYukun Cui, Airu Niu, Richard Pestell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemopreventionIndira Poola, Suzanne A W Fuqua, Robert L De Witty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancerTorsten A Hopp, Heidi L Weiss, Irma S Parra, et al.
Molecular Cancer Therapeutics|December 19, 2006
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cellsMatthew H Herynk, Amanda R Beyer, Yukun Cui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancerMatthew H Herynk, Irma Parra, Yukun Cui, et al.
Molecular Endocrinology (Baltimore, Md.)|March 23, 2010
Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulatorKazufumi Ohshiro, Prakriti Mudvari, Qing-chang Meng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 9, 2011
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cellsFrancesca De Amicis, Francesca Giordano, Adele Vivacqua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival ratesTorsten A Hopp, Heidi L Weiss, Susan G Hilsenbeck, et al.
Cancer Research|June 3, 2009
Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathwayInes Barone, Yukun Cui, Matthew H Herynk, et al.
Breast Cancer Research and Treatment|October 22, 2015
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancerAndrew Ciupek, Yassine Rechoum, Guowei Gu, et al.
Pageof 7